Price target
1,864.410.000.00%
The 34 analysts offering 1 year price forecasts for SUNPHARMA have a max estimate of — and a min estimate of —.
Analyst rating
Based on 34 analysts giving stock ratings to SUNPHARMA in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
SUNPHARMA EPS for the last quarter is 11.80 INR despite the estimation of 10.51 INR. In the next quarter EPS is expected to reach 12.06 INR. Track more of SUN PHARMACEUTICAL INDUSTRIES financials and stay on top of what is up with the company.
In the next quarter SUN PHARMACEUTICAL INDUSTRIES revenue is expected to reach 132.98 B INR. Check out SUN PHARMACEUTICAL INDUSTRIES revenue and earnings and make informed decisions.
According to analysts, SUNPHARMA price target is 1,864.41 INR with a max estimate of 2,450.00 INR and a min estimate of 1,450.00 INR. Check if this forecast comes true in a year, meanwhile watch SUN PHARMACEUTICAL INDUSTRIES stock price chart and keep track of the current situation with SUNPHARMA news and stock market news.
We've gathered opinions of 34 analysts rating SUNPHARMA stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.